Local delivery of doxorubicin prodrug via lipid nanocapsule–based hydrogel for the treatment of glioblastoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Local delivery of doxorubicin prodrug via lipid nanocapsule–based hydrogel for the treatment of glioblastoma ; day:27 ; month:10 ; year:2023 ; pages:1-17
Drug Delivery and Translational Research ; (27.10.2023), 1-17
- Creator
-
Wang, Mingchao
Bergès, Raphaël
Malfanti, Alessio
Préat, Véronique
Bastiancich, Chiara
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13346-023-01456-y
- URN
-
urn:nbn:de:101:1-2024011514231360505900
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Mingchao
- Bergès, Raphaël
- Malfanti, Alessio
- Préat, Véronique
- Bastiancich, Chiara
- SpringerLink (Online service)
Other Objects (12)
Ultrasound-directed enzyme-prodrug therapy (UDEPT) using self-immolative doxorubicin derivatives
Modular Lipid Nanoparticle Platform Technology for siRNA and Lipophilic Prodrug Delivery
A Doxorubicin-Glucuronide Prodrug Released from Nanogels Activated by High-Intensity Focused Ultrasound Liberated β-Glucuronidase
Hydrogel-based platforms for site-specific doxorubicin release in cancer therapy
The effect of doxorubicin curcumin co-loaded lipid nanoparticles and doxorubicin on osteosarcoma before surgery
Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy
Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristine
Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical study
Lipid‐Based Nanocarriers for The Treatment of Glioblastoma
The Temozolomide–Doxorubicin paradox in Glioblastoma in vitro–in silico preclinical drug-screening
Efficient chemotherapy of rat glioblastoma using Doxorubicin-loaded PLGA nanoparticles with different stabilizers
Neue Prodrug-Prinzipien für Amidine
Ultrasound-directed enzyme-prodrug therapy (UDEPT) using self-immolative doxorubicin derivatives
Modular Lipid Nanoparticle Platform Technology for siRNA and Lipophilic Prodrug Delivery
A Doxorubicin-Glucuronide Prodrug Released from Nanogels Activated by High-Intensity Focused Ultrasound Liberated β-Glucuronidase
Hydrogel-based platforms for site-specific doxorubicin release in cancer therapy
The effect of doxorubicin curcumin co-loaded lipid nanoparticles and doxorubicin on osteosarcoma before surgery
Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy
Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristine
Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical study
Lipid‐Based Nanocarriers for The Treatment of Glioblastoma
The Temozolomide–Doxorubicin paradox in Glioblastoma in vitro–in silico preclinical drug-screening
Efficient chemotherapy of rat glioblastoma using Doxorubicin-loaded PLGA nanoparticles with different stabilizers
Neue Prodrug-Prinzipien für Amidine
Ultrasound-directed enzyme-prodrug therapy (UDEPT) using self-immolative doxorubicin derivatives
Modular Lipid Nanoparticle Platform Technology for siRNA and Lipophilic Prodrug Delivery
A Doxorubicin-Glucuronide Prodrug Released from Nanogels Activated by High-Intensity Focused Ultrasound Liberated β-Glucuronidase
Hydrogel-based platforms for site-specific doxorubicin release in cancer therapy
The effect of doxorubicin curcumin co-loaded lipid nanoparticles and doxorubicin on osteosarcoma before surgery
Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy
Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristine
Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical study
Lipid‐Based Nanocarriers for The Treatment of Glioblastoma
The Temozolomide–Doxorubicin paradox in Glioblastoma in vitro–in silico preclinical drug-screening
Efficient chemotherapy of rat glioblastoma using Doxorubicin-loaded PLGA nanoparticles with different stabilizers